Fig. 1 · Structure

Documents & Downloads

KD 5170

Cat. No. A15354 CAS 940943-37-3

HDAC inhibitor

KD 5170, a novel mercaptoketone-based histone deacetylase inhibitor that exhibits broad spectrum antitumor activity in vitro and in vivo.

In Stock

Free Aliquoting for Your Order

Tell us your preferred amount per vial. We’ll confirm the options.

Biological Activity

Cellular Effect

Cell Line Activity Value Description Reference
HeLa EC50 25 nM Inhibition of HDAC in human HeLa cells assessed as histone H3 hyperacetylation after 7 hrs 10.1039/C1MD00199J
HeLa EC50 325 nM Inhibition of HDAC in human HeLa cells assessed as alpha-tubulin acetylation after 7 hrs 10.1039/C1MD00199J
HeLa IC50 45 nM Inhibition of HDAC isolated from human HeLa cell nuclear extracts using Fluor de Lys as substrate after 30 mins by fluorescence assay 10.1039/C1MD00199J

Specifications

Manufacturer Adooq Bioscience
Actions Inhibitor
CAS Number 940943-37-3
Applications HDAC inhibitor
Formula C20H25N3O5S2
Molecular Weight 451.56
SMILES
CC(=O)SCC(=O)C1=CN=C(C=C1)NS(=O)(=O)C2=CC=C(C=C2)OCCCN(C)C

Storage & Solubility

In Vitro Solubility

Reported Solubility

No reported solubility data are available for this product.

Preparing Stock Solutions

Stock preparation is unavailable for this product molecular weight.

Calculated stock concentrations do not establish solvent solubility. Refer to the reported solubility data for experimental guidance.

Storage

Store powder at -20°C, keep desiccated.
In powder form, the chemical is stable for 36 months.
In solution, store at -20°C and use within 1 month to prevent loss of potency. Aliquot to avoid multiple freeze/thaw cycles.

Added to your cart

View Cart Checkout
Loading...